Latest On Tonix Pharmaceuticals Holding Corp (TNXP):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-09 19:05 EST | News | Tonix Pharma falls 30% after announcing another reverse stock split | N/A |  |
| 2023-05-08 16:12 EST | News | Tonix Pharmaceuticals GAAP EPS of -$0.52 | N/A | |
| 2023-05-04 17:32 EST | News | Tonix Pharmas' TNX-1500 cleared for IND to prevent organ rejection in kidney transplant patients | N/A | |
| 2023-04-04 21:25 EST | News | Tonix puts COVID programs on the back burner in portfolio overhaul | N/A | |
| 2023-03-29 19:09 EST | News | Tonix Pharmaceuticals (TNXP) Investor presentation - Slideshow | N/A | |
| 2023-03-16 08:36 EST | News | Tonix starts enrollment in mid-stage study of depression drug TNX-601 ER | N/A | |
| 2023-03-13 19:49 EST | News | Tonix Pharmaceuticals GAAP EPS of -$0.56 beats by $0.30 | N/A | |
| 2023-03-07 10:41 EST | News | Tonix Pharma rises on positive data from preclinical study of colorectal cancer therapy | N/A | |
| 2023-02-02 10:12 EST | News | Tonix buys preclinical antiviral portfolio from Healion Bio | N/A | |
| 2023-02-01 21:58 EST | News | Tonix Pharma collaborates to study TNX-1500 to prevent rejection in heart xenograft transplantation | N/A | |
| 2022-12-12 20:41 EST | News | Tonix stock surges 20% on licensing deal for antibodies for COVID-19 | N/A | |
| 2022-11-07 08:53 EST | News | Tonix Pharmaceuticals GAAP EPS of -$0.69 beats by $0.33 | N/A | |
| 2022-10-25 17:27 EST | News | Tonix Pharmaceuticals rises on pricing $15M preferred stock offering | N/A | |
| 2022-10-03 17:13 EST | News | Tonix stock rises on FDA nod to start trial of TNX-601 for depression | N/A | |
| 2022-08-08 09:36 EST | News | Tonix Pharmaceuticals GAAP EPS of -$1.22 beats by $0.23 | N/A | |
| 2022-08-02 21:49 EST | News | Tonix gets federal grant to develop TNX-1300 for treating cocaine intoxication | N/A | |
| 2022-08-01 16:44 EST | News | Monkeypox plays rally as New York calls outbreak a public emergency | N/A | |
| 2022-07-28 15:09 EST | News | Tonix announces partnership to study monkeypox vaccine in H1 2023 | N/A | |
| 2022-07-25 19:27 EST | News | Tonix Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement | N/A | |
| 2022-07-11 09:12 EST | News | Tonix Pharma to develop extended-release form of depression therapy | N/A | |
| 2022-07-05 20:47 EST | News | Tonix gains as CEO buys 20K company shares | N/A | |
| 2022-06-22 08:47 EST | News | Tonix Pharmaceuticals raises $30M via private placement of convertible redeemable preferred stock | N/A | |
| 2022-06-21 16:25 EST | News | Is Tonix Pharma's Stock A Buy Or Sell After Buyback Plan Announcement? | N/A | |
| 2022-06-16 08:33 EST | News | Tonix to open new site in Massachusetts for vaccine programs including monkeypox/smallpox | N/A | |
| 2022-06-01 21:49 EST | News | Tonix gains on U.S. patent win for monkeypox vaccine technology | N/A | |
| 2022-06-01 05:37 EST | News | Tonix Pharma announces share buyback plan | N/A | |
| 2022-05-16 20:17 EST | News | Tonix Pharmaceuticals stock slumps ~21% on eve of 1-for-32 reverse stock split | N/A | |
| 2022-05-09 17:52 EST | News | Tonix Pharmaceuticals GAAP EPS of -$0.05 | N/A | |
| 2022-04-20 19:32 EST | News | Tonix backs mid-stage trial with data on Long COVID patients with multi-site pain | N/A | |
| 2022-04-07 14:05 EST | News | Tonix Pharma rises on starting late-stage trial of fibromyalgia drug candidate | N/A | |
| 2022-04-06 22:17 EST | News | Tonix Pharma wins FDA clearance for Long COVID trial | N/A | |
| 2022-04-05 15:16 EST | News | Tonix Pharma to develop live-virus vaccine against COVID-19 with Kansas State University | N/A | |
| 2022-03-22 05:11 EST | News | Tonix Pharma says late-stage trial for fibromyalgia candidate did not reach main goal | N/A | |
| 2022-03-14 17:39 EST | News | Tonix Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01 | N/A | |
| 2022-03-03 18:49 EST | News | Tonix wins FDA’s Orphan Drug Designation for candidate targeting genetic disorder | N/A | |
| 2022-01-04 19:17 EST | News | Tonix Pharma collaborates with Kansas State University to develop LNP-free mRNA vaccines | N/A | |
| 2021-12-14 23:05 EST | News | Tonix Pharma to commence TNX-2100 study to measure COVID-19 exposure and T cell immunity | N/A | |
| 2021-11-23 09:31 EST | News | Tonix Pharma rises after announcing publication of study on COVID-19 antiviral | N/A | |
| 2021-11-23 09:29 EST | News | Tonix Pharma extends gains with FDA clearance to start trial for migraine therapy | N/A | |
| 2021-11-08 20:02 EST | News | Tonix Pharmaceuticals shares rise 7% after positive results from late-stage TNX-102 SL study | N/A | |
| 2021-10-01 22:48 EST | News | Tonix Pharmaceuticals Holding (TNXP) Investor Presentation - Slideshow | N/A | |
| 2021-09-23 13:43 EST | News | Tonix Pharmaceuticals expands COVID-19 research collaboration with Columbia University | N/A | |
| 2021-09-22 08:25 EST | News | Tonix Pharma gets FDA response ahead of studies for live virus COVID-19 shot | N/A | |
| 2021-09-22 08:18 EST | News | Tonix Pharmaceuticals Holding Corp (TNXP) Investor Presentation - slideshow | N/A | |
| 2021-08-24 11:23 EST | News | Tonix Pharma plans to submit IND for mid-stage TNX-102 SL study in Long COVID | N/A | |
| 2021-08-10 13:08 EST | News | Tonix Pharmaceuticals EPS in-line | N/A | |
| 2021-07-27 17:34 EST | News | Tonix Pharma pops 8% on acquisition of R&D facility in Maryland | N/A | |
| 2021-07-24 01:48 EST | News | Tonix Pharma halts enrollment of fibromyalgia trial on panel recommendation | N/A | |
| 2021-07-22 04:37 EST | News | Tonix to develop candidate as potential treatment for Long COVID Syndrome | N/A | |
| 2021-07-22 04:28 EST | News | Tonix Pharma rises on updates of a vaccine manufacturing site | N/A | |
About Tonix Pharmaceuticals Holding Corp (TNXP):
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, manufacturing, and licensing small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead vaccine candidate is TNX-1800, a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19. Its vaccines also comprise TNX-801, a live horsepox virus vaccine to protect against smallpox and monkeypox and serves as the vector platform; and TNX-2300 and TNX-2600, which are live replicating attenuated vaccine candidates for the prevention of COVID-19. In addition, the company's lead CNS candidate is TNX-102 SL, a sublingual formulation of cyclobenzaprine, which is in Phase 3 development for fibromyalgia, as well as in Phase 2 studies for agitation in Alzheimer's disease and alcohol use disorder. Further, its products include TNX-1300, which is in Phase 2 development for the treatment of life-threatening cocaine intoxication; TNX-601 CR for depression; and TNX-1900 for migraine and cranio-facial pain treatment. Additionally, its preclinical pipeline includes TNX-1600 for posttraumatic stress disorder, depression, and attention deficit hyperactivity disorder; TNX-701 for radioprotection; TNX-1200, a smallpox vaccine; TNX-1500 for transplant organ rejection and autoimmune conditions; and TNX-1700 for gastric and pancreatic cancers. The company is headquartered in Chatham, New Jersey.
General
- Name Tonix Pharmaceuticals Holding Corp
- Symbol TNXP
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 26
- Last Split Factor1:10
- Last Split Date2019-11-01
- Fiscal Year EndDecember
- IPO Date2012-05-10
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.tonixpharma.com
View More
Valuation
- Trailing PE 0.14
- Price/Book (Most Recent Quarter) 5.54
- Enterprise Value EBITDA 0.02
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.20
- Next Year EPS Estimate -$0.18
- Next Quarter EPS Estimate -$0.05
- Return on Assets -56%
- Return on Equity -104%
- Earnings Per Share -$8.25
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 443.77 million
- EBITDA -25354000
- Analyst Target Price $3.75
- Book Value Per Share $0.43
View More
Share Statistics
- Shares Outstanding 323.92 million
- Shares Float 323.68 million
- % Held by Insiders 5%
- % Held by Institutions 5.25%
- Shares Short 1.68 million
- Shares Short Prior Month 4.74 million
- Short Ratio 0.03
- Short % of Float 1%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 1.34
- 52 Week High $2.12
- 52 Week Low $0.51
- 50 Day Moving Average 1.29
- 200 Day Moving Average 0.87
View More
Dividends
- Dividend Date 2019-11-01
- ExDividend Date N/A
- Dividend Yield 0%
View More
Tonix Pharmaceuticals Holding Corp (TNXP) Dividend Calendar:
TNXP's last dividend payment was made to shareholders on November 1, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-22 | $N/A | -$0.10 | -$0.09 | -11.11% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.09 | -$0.11 | 18.18% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.23 | -$0.21 | -9.52% |
| 2020-03-31 | 2020-05-12 | $N/A | -$0.37 | -$0.21 | -76.19% |
| 2019-12-31 | 2020-03-24 | $N/A | -$2.86 | -$1.49 | -91.95% |
| 2019-09-30 | 2019-11-08 | $N/A | -$5.69 | -$4.35 | -30.8% |
| 2019-06-30 | 2019-08-12 | $N/A | -$9.50 | -$9.60 | 1.04% |
| 2019-03-31 | 2019-05-13 | $N/A | -$12.90 | -$11.95 | -7.95% |
| 2018-12-31 | 2019-03-18 | $N/A | -$61.00 | -$38.70 | -57.62% |
| 2018-09-30 | 2018-11-09 | $N/A | -$57.00 | -$60.80 | 6.25% |
| 2018-06-30 | 2018-08-13 | $N/A | -$73.00 | -$76.20 | 4.2% |
| 2018-03-31 | 2018-05-11 | $N/A | -$88.00 | -$69.67 | -26.32% |
| 2017-12-31 | 2018-03-09 | $N/A | -$68.00 | -$76.33 | 10.92% |
| 2017-09-30 | 2017-11-06 | $N/A | -$77.00 | -$68.00 | -13.24% |
| 2017-06-30 | 2017-08-11 | $N/A | -$65.00 | -$74.33 | 12.56% |
| 2017-03-31 | 2017-05-12 | $N/A | -$127.00 | -$109.50 | -15.98% |
| 2016-12-31 | 2016-12-31 | $N/A | -$2.97 | -$1.30 | -128.46% |
| 2016-09-30 | 2016-11-10 | $N/A | -$290.00 | -$340.00 | 14.71% |
| 2016-06-30 | 2016-08-05 | $N/A | -$500.00 | -$552.50 | 9.5% |
| 2016-03-31 | 2016-05-06 | $N/A | -$740.00 | -$620.00 | -19.35% |
| 2015-12-31 | 2016-03-03 | $N/A | -$710.00 | -$635.00 | -11.81% |
| 2015-09-30 | 2015-11-09 | $N/A | -$7.20 | -$6.20 | -16.13% |
| 2015-06-30 | 2015-08-07 | $N/A | -$7.30 | -$6.50 | -12.31% |
| 2015-03-31 | 2015-05-08 | $N/A | -$7.10 | -$5.35 | -32.71% |
| 2014-12-31 | 2015-03-03 | $N/A | -$8.30 | -$8.10 | -2.47% |
| 2014-09-30 | 2014-11-07 | $N/A | -$0.71 | -$0.69 | -2.9% |
| 2014-06-30 | 2014-08-08 | $N/A | -$610.00 | -$530.00 | -15.09% |
| 2014-03-31 | 2014-05-13 | $N/A | -$590.00 | -$350.00 | -68.57% |
| 2013-12-31 | 2014-03-31 | $N/A | -$740.00 | -$460.00 | -60.87% |
| 2013-09-30 | 2013-11-13 | $N/A | -$870.00 | -$640.00 | -35.94% |
| 2013-06-30 | 2013-08-28 | $N/A | -$953.86 | ||
| 2013-03-31 | 2013-05-29 | $N/A | -$926.86 | ||
| 2012-12-31 | 2012-12-31 | $N/A | -$1,552.42 | ||
| 2012-09-30 | 2012-09-30 | $1875 | -$1,010.56 | ||
| 2012-06-30 | 2012-06-30 | $N/A | -$1,793.37 | ||
| 2012-03-31 | 2012-03-31 | $N/A | -$1,175.66 |
Tonix Pharmaceuticals Holding Corp (TNXP) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Tonix Pharmaceuticals Holding Corp (TNXP) Chart:
Tonix Pharmaceuticals Holding Corp (TNXP) News:
Below you will find a list of latest news for Tonix Pharmaceuticals Holding Corp (TNXP) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Tonix Pharmaceuticals Holding Corp (TNXP) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest TNXP Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 102 | $1.765 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.765 |
| Jun 13, 2022 7:59 PM EST | 3 | $1.765 |
| Jun 13, 2022 7:59 PM EST | 2 | $1.765 |
| Jun 13, 2022 7:59 PM EST | 25 | $1.765 |
Tonix Pharmaceuticals Holding Corp (TNXP) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005991/0001387131-20-005991-index.htm |
| 2019-06-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1430306/000000000019010237/0000000000-19-010237-index.htm |
| 2019-09-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1430306/000000000019013135/0000000000-19-013135-index.htm |
| 2019-10-25 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1430306/000000000019014868/0000000000-19-014868-index.htm |
| 2020-01-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1430306/000000000020000663/0000000000-20-000663-index.htm |
| 2020-04-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1430306/000000000020003226/0000000000-20-003226-index.htm |
| 2019-11-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000091957419007440/0000919574-19-007440-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000091957420001635/0000919574-20-001635-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000093041320000363/0000930413-20-000363-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000103738920000060/0001037389-20-000060-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000110465920013403/0001104659-20-013403-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000110465920020861/0001104659-20-020861-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119001982/0001387131-19-001982-index.htm |
| 2019-03-18 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002012/0001387131-19-002012-index.htm |
| 2019-03-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002014/0001387131-19-002014-index.htm |
| 2019-03-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002230/0001387131-19-002230-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002339/0001387131-19-002339-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002513/0001387131-19-002513-index.htm |
| 2019-04-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002759/0001387131-19-002759-index.htm |
| 2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002782/0001387131-19-002782-index.htm |
| 2019-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002832/0001387131-19-002832-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003403/0001387131-19-003403-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003409/0001387131-19-003409-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003410/0001387131-19-003410-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003411/0001387131-19-003411-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003412/0001387131-19-003412-index.htm |
| 2019-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003413/0001387131-19-003413-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003422/0001387131-19-003422-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003423/0001387131-19-003423-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003424/0001387131-19-003424-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003425/0001387131-19-003425-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003426/0001387131-19-003426-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003427/0001387131-19-003427-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003428/0001387131-19-003428-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003429/0001387131-19-003429-index.htm |
| 2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003509/0001387131-19-003509-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003510/0001387131-19-003510-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003791/0001387131-19-003791-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119003896/0001387131-19-003896-index.htm |
| 2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004031/0001387131-19-004031-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004172/0001387131-19-004172-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004402/0001387131-19-004402-index.htm |
| 2019-06-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004459/0001387131-19-004459-index.htm |
| 2019-06-19 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004490/0001387131-19-004490-index.htm |
| 2019-07-01 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004759/0001387131-19-004759-index.htm |
| 2019-07-03 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004799/0001387131-19-004799-index.htm |
| 2019-07-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004919/0001387131-19-004919-index.htm |
| 2019-07-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004920/0001387131-19-004920-index.htm |
| 2019-07-11 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004970/0001387131-19-004970-index.htm |
| 2019-07-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119004989/0001387131-19-004989-index.htm |
| 2019-07-15 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005027/0001387131-19-005027-index.htm |
| 2019-07-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005029/0001387131-19-005029-index.htm |
| 2019-07-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005031/0001387131-19-005031-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005074/0001387131-19-005074-index.htm |
| 2019-07-16 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005112/0001387131-19-005112-index.htm |
| 2019-07-16 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005114/0001387131-19-005114-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005324/0001387131-19-005324-index.htm |
| 2019-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005698/0001387131-19-005698-index.htm |
| 2019-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005974/0001387131-19-005974-index.htm |
| 2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119005975/0001387131-19-005975-index.htm |
| 2019-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006259/0001387131-19-006259-index.htm |
| 2019-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006300/0001387131-19-006300-index.htm |
| 2019-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006320/0001387131-19-006320-index.htm |
| 2019-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006371/0001387131-19-006371-index.htm |
| 2019-08-23 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006373/0001387131-19-006373-index.htm |
| 2019-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006591/0001387131-19-006591-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006664/0001387131-19-006664-index.htm |
| 2019-09-06 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006791/0001387131-19-006791-index.htm |
| 2019-09-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006792/0001387131-19-006792-index.htm |
| 2019-09-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006817/0001387131-19-006817-index.htm |
| 2019-09-12 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006893/0001387131-19-006893-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006945/0001387131-19-006945-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119006954/0001387131-19-006954-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119007392/0001387131-19-007392-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119007460/0001387131-19-007460-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119007657/0001387131-19-007657-index.htm |
| 2019-10-18 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119007745/0001387131-19-007745-index.htm |
| 2019-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119007828/0001387131-19-007828-index.htm |
| 2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008088/0001387131-19-008088-index.htm |
| 2019-11-01 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008150/0001387131-19-008150-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008151/0001387131-19-008151-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008187/0001387131-19-008187-index.htm |
| 2019-11-01 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008189/0001387131-19-008189-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008236/0001387131-19-008236-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008237/0001387131-19-008237-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008474/0001387131-19-008474-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008487/0001387131-19-008487-index.htm |
| 2019-11-08 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008488/0001387131-19-008488-index.htm |
| 2019-11-14 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008666/0001387131-19-008666-index.htm |
| 2019-11-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008667/0001387131-19-008667-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008759/0001387131-19-008759-index.htm |
| 2019-11-14 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008761/0001387131-19-008761-index.htm |
| 2019-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008807/0001387131-19-008807-index.htm |
| 2019-11-18 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008844/0001387131-19-008844-index.htm |
| 2019-11-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008875/0001387131-19-008875-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119008948/0001387131-19-008948-index.htm |
| 2019-11-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009015/0001387131-19-009015-index.htm |
| 2019-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009119/0001387131-19-009119-index.htm |
| 2019-12-02 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009281/0001387131-19-009281-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009300/0001387131-19-009300-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009327/0001387131-19-009327-index.htm |
| 2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009456/0001387131-19-009456-index.htm |
| 2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009493/0001387131-19-009493-index.htm |
| 2019-12-13 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009537/0001387131-19-009537-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009561/0001387131-19-009561-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009599/0001387131-19-009599-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009774/0001387131-19-009774-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000095/0001387131-20-000095-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000227/0001387131-20-000227-index.htm |
| 2020-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000309/0001387131-20-000309-index.htm |
| 2020-01-21 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000350/0001387131-20-000350-index.htm |
| 2020-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000428/0001387131-20-000428-index.htm |
| 2020-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000454/0001387131-20-000454-index.htm |
| 2020-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000651/0001387131-20-000651-index.htm |
| 2020-01-29 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713120000652/0001387131-20-000652-index.htm |
| 2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001046/0001387131-20-001046-index.htm |
| 2020-02-05 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001048/0001387131-20-001048-index.htm |
| 2020-02-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001061/0001387131-20-001061-index.htm |
| 2020-02-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001062/0001387131-20-001062-index.htm |
| 2020-02-06 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001063/0001387131-20-001063-index.htm |
| 2020-02-06 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001136/0001387131-20-001136-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001163/0001387131-20-001163-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001199/0001387131-20-001199-index.htm |
| 2020-02-11 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001265/0001387131-20-001265-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001300/0001387131-20-001300-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001746/0001387131-20-001746-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001792/0001387131-20-001792-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120001794/0001387131-20-001794-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002149/0001387131-20-002149-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002251/0001387131-20-002251-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002253/0001387131-20-002253-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002255/0001387131-20-002255-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002257/0001387131-20-002257-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002363/0001387131-20-002363-index.htm |
| 2020-02-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002365/0001387131-20-002365-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002483/0001387131-20-002483-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120002994/0001387131-20-002994-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003042/0001387131-20-003042-index.htm |
| 2020-03-24 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003189/0001387131-20-003189-index.htm |
| 2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003190/0001387131-20-003190-index.htm |
| 2020-03-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003461/0001387131-20-003461-index.htm |
| 2020-04-08 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003786/0001387131-20-003786-index.htm |
| 2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003792/0001387131-20-003792-index.htm |
| 2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003841/0001387131-20-003841-index.htm |
| 2020-04-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003915/0001387131-20-003915-index.htm |
| 2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120003992/0001387131-20-003992-index.htm |
| 2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004018/0001387131-20-004018-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004087/0001387131-20-004087-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004346/0001387131-20-004346-index.htm |
| 2020-05-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004416/0001387131-20-004416-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004481/0001387131-20-004481-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004483/0001387131-20-004483-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004485/0001387131-20-004485-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004487/0001387131-20-004487-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004489/0001387131-20-004489-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004491/0001387131-20-004491-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004493/0001387131-20-004493-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004495/0001387131-20-004495-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004497/0001387131-20-004497-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004499/0001387131-20-004499-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004515/0001387131-20-004515-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004573/0001387131-20-004573-index.htm |
| 2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004639/0001387131-20-004639-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004640/0001387131-20-004640-index.htm |
| 2020-05-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004903/0001387131-20-004903-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004919/0001387131-20-004919-index.htm |
| 2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120004959/0001387131-20-004959-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005058/0001387131-20-005058-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005354/0001387131-20-005354-index.htm |
| 2020-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005497/0001387131-20-005497-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005565/0001387131-20-005565-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005616/0001387131-20-005616-index.htm |
| 2020-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005619/0001387131-20-005619-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005621/0001387131-20-005621-index.htm |
| 2020-06-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005650/0001387131-20-005650-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005750/0001387131-20-005750-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005811/0001387131-20-005811-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005825/0001387131-20-005825-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005991/0001387131-20-005991-index.htm |
| 2020-06-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1430306/000138713120005992/0001387131-20-005992-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006196/0001387131-20-006196-index.htm |
| 2020-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006280/0001387131-20-006280-index.htm |
| 2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006326/0001387131-20-006326-index.htm |
| 2020-07-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006372/0001387131-20-006372-index.htm |
| 2020-07-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006373/0001387131-20-006373-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006424/0001387131-20-006424-index.htm |
| 2020-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006436/0001387131-20-006436-index.htm |
| 2020-07-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006585/0001387131-20-006585-index.htm |
| 2020-07-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006587/0001387131-20-006587-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120006956/0001387131-20-006956-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007002/0001387131-20-007002-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007085/0001387131-20-007085-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007238/0001387131-20-007238-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007240/0001387131-20-007240-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007591/0001387131-20-007591-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007592/0001387131-20-007592-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007593/0001387131-20-007593-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007594/0001387131-20-007594-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007638/0001387131-20-007638-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007672/0001387131-20-007672-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007758/0001387131-20-007758-index.htm |
| 2020-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008026/0001387131-20-008026-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008104/0001387131-20-008104-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008117/0001387131-20-008117-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008155/0001387131-20-008155-index.htm |
| 2020-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008174/0001387131-20-008174-index.htm |
| 2020-09-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008175/0001387131-20-008175-index.htm |
| 2020-09-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008176/0001387131-20-008176-index.htm |
| 2020-09-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008310/0001387131-20-008310-index.htm |
| 2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008345/0001387131-20-008345-index.htm |
| 2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008557/0001387131-20-008557-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008712/0001387131-20-008712-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120009012/0001387131-20-009012-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120009023/0001387131-20-009023-index.htm |
| 2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1430306/000138713120009504/0001387131-20-009504-index.htm |
| 2020-01-21 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000153561020000044/0001535610-20-000044-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1430306/000153561020000068/0001535610-20-000068-index.htm |
| 2019-07-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1430306/999999999519001601/9999999995-19-001601-index.htm |
| 2019-09-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1430306/999999999519002067/9999999995-19-002067-index.htm |
| 2019-11-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1430306/999999999519002571/9999999995-19-002571-index.htm |
| 2020-02-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1430306/999999999520000276/9999999995-20-000276-index.htm |
| 2020-04-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1430306/999999999520000785/9999999995-20-000785-index.htm |
| 2020-02-04 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1430306/999999999720000453/9999999997-20-000453-index.htm |
| 2020-02-18 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1430306/999999999720000772/9999999997-20-000772-index.htm |
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tonix Pharmaceuticals Holding Corp (TNXP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 5%Institutional Ownership: 525%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-31 | James Treco | Director | Buy | 5,500.00 | 0.89 | 4,895.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120008117/0001387131-20-008117-index.htm |
| 2020-08-13 | RICHARD H BAGGER | Director | Buy | 10,000.00 | 0.91 | 9,100.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007591/0001387131-20-007591-index.htm |
| 2020-08-17 | GREGORY M SULLIVAN | Chief Medical Officer | Buy | 20,000.00 | 1.03 | 20,600.00 | 21,405.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007672/0001387131-20-007672-index.htm |
| 2019-12-03 | SETH LEDERMAN | Chief Executive Officer | Buy | 20,000.00 | 1.16 | 23,180.00 | 23,267.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119009327/0001387131-19-009327-index.htm |
| 2019-03-26 | SETH LEDERMAN | Chief Executive Officer | Buy | 25,000.00 | 2.38 | 59,375.00 | 27,670.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002230/0001387131-19-002230-index.htm |
| 2019-03-29 | SETH LEDERMAN | Chief Executive Officer | Buy | 5,000.00 | 2.49 | 12,440.00 | 32,670.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713119002339/0001387131-19-002339-index.htm |
| 2020-08-14 | James Treco | Director | Buy | 4,500.00 | 1.06 | 4,770.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007594/0001387131-20-007594-index.htm |
| 2020-08-13 | ADEOYE Y OLUKOTUN | Director | Buy | 5,350.00 | 0.94 | 5,029.00 | 5,350.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007593/0001387131-20-007593-index.htm |
| 2020-08-20 | Margaret Smith Bell | Director | Buy | 5,391.00 | 0.93 | 4,997.46 | 5,391.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007758/0001387131-20-007758-index.htm |
| 2020-08-13 | SETH LEDERMAN | Chief Executive Officer | Buy | 60,000.00 | 0.91 | 54,600.00 | 83,267.00 | https://www.sec.gov/Archives/edgar/data/1430306/000138713120007592/0001387131-20-007592-index.htm |